Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)
- Response deadline
- Dec 14, 2026 Due in 65 days
- Date posted
- Oct 9, 2026
- Source
- Open notice
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to develop, apply, and test predictive models and perform integrative analyses to determine the impact of genomic variation on genome function. Centers funded through this initiative will become a part of the Impact of Genomic Variation on Function (IGVF) Consortium. As consortium members, centers will work together to ensure all consortium resources are accessible to a wide variety of potential users. Centers also will collaborate with other consortium components to guide and optimize IGVF experimental design, to provide analytical expertise and support for consortium-wide efforts, and to develop and execute shared analysis strategies to meet consortium goals.
Classifications
- NAICS93.172
Documents (1)
- RFA-HG-27-010-Full-Announcement.htmltext/html;charset=UTF-8162 KBNot yet available
Contacts
Similar contracts
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)Due Dec 14, 2026
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)Due Dec 14, 2026
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)Due Dec 14, 2026
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional)Due Oct 30, 2026
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Due Oct 30, 2026
- GREGoRi Innovation Projects (U01 Clinical Trial Optional)Due Oct 30, 2026